Smith, L. (2016) “The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy”, Journal of Pharmacy & Pharmaceutical Sciences, 19(1), pp. 137–146. doi: 10.18433/J3J02P.